Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

David Andrew Morrow, M.D.

Co-Author

This page shows the publications co-authored by David Morrow and David Berg.
Connection Strength

12.124
  1. Improving prediction of anticoagulant-related major bleeding in atrial fibrillation: The search for new biomarkers. J Thromb Haemost. 2021 11; 19(11):2674-2676.
    View in: PubMed
    Score: 0.993
  2. A Biomarker-Based Score for Risk of Hospitalization for Heart Failure in Patients With Diabetes. Diabetes Care. 2021 Nov; 44(11):2573-2581.
    View in: PubMed
    Score: 0.985
  3. A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48. J Am Coll Cardiol. 2021 Aug 10; 78(6):634-636.
    View in: PubMed
    Score: 0.978
  4. Epidemiology and causes of cardiogenic shock. Curr Opin Crit Care. 2021 08 01; 27(4):401-408.
    View in: PubMed
    Score: 0.976
  5. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2°P-TIMI 50. J Am Heart Assoc. 2021 05 04; 10(9):e018673.
    View in: PubMed
    Score: 0.958
  6. Biomarkers for Risk Assessment in Atrial Fibrillation. Clin Chem. 2021 01 08; 67(1):87-95.
    View in: PubMed
    Score: 0.939
  7. Efficacy and Safety of Sacubitril/Valsartan by Dose Level Achieved in the PIONEER-HF Trial. JACC Heart Fail. 2020 10; 8(10):834-843.
    View in: PubMed
    Score: 0.913
  8. Clinical Practice Patterns in Temporary Mechanical Circulatory Support for Shock in the Critical Care Cardiology Trials Network (CCCTN) Registry. Circ Heart Fail. 2019 11; 12(11):e006635.
    View in: PubMed
    Score: 0.866
  9. Epidemiology of Shock in Contemporary Cardiac Intensive Care Units. Circ Cardiovasc Qual Outcomes. 2019 03; 12(3):e005618.
    View in: PubMed
    Score: 0.825
  10. Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients With Atrial Fibrillation in ENGAGE AF-TIMI 48. Circulation. 2019 02 05; 139(6):760-771.
    View in: PubMed
    Score: 0.822
  11. Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50). Am J Cardiol. 2016 Apr 01; 117(7):1055-8.
    View in: PubMed
    Score: 0.665
  12. Outcomes in patients undergoing percutaneous ventricular assist device implantation for cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2016 Apr; 5(2):108-16.
    View in: PubMed
    Score: 0.633
  13. De Novo vs Acute-on-Chronic Presentations of Heart Failure-Related Cardiogenic Shock: Insights from the Critical Care Cardiology Trials Network Registry. J Card Fail. 2021 Oct; 27(10):1073-1081.
    View in: PubMed
    Score: 0.247
  14. Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial. Eur Heart J. 2021 05 01; 42(17):1698-1706.
    View in: PubMed
    Score: 0.240
  15. Biomarkers of platelet activation and cardiovascular risk in the DAPT trial. J Thromb Thrombolysis. 2021 Apr; 51(3):675-681.
    View in: PubMed
    Score: 0.238
  16. Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial. Circ Heart Fail. 2021 02; 14(2):e007034.
    View in: PubMed
    Score: 0.236
  17. Modes and timing of death in 66?252 patients with non-ST-segment elevation acute coronary syndromes enrolled in 14 TIMI trials. Eur Heart J. 2018 11 07; 39(42):3810-3820.
    View in: PubMed
    Score: 0.202
  18. Editor's Choice-Prospective registry of cardiac critical illness in a modern tertiary care Cardiac Intensive Care Unit. Eur Heart J Acute Cardiovasc Care. 2019 Dec; 8(8):755-761.
    View in: PubMed
    Score: 0.198
  19. Management and Outcomes of Cardiogenic Shock in Cardiac ICUs With Versus Without Shock Teams. J Am Coll Cardiol. 2021 Sep 28; 78(13):1309-1317.
    View in: PubMed
    Score: 0.062
  20. The Range of Cardiogenic Shock Survival by Clinical Stage: Data From the Critical Care Cardiology Trials Network Registry. Crit Care Med. 2021 08 01; 49(8):1293-1302.
    View in: PubMed
    Score: 0.061
  21. Use of Temporary Mechanical Circulatory Support for Management of Cardiogenic Shock Before and After the United Network for Organ Sharing Donor Heart Allocation System Changes. JAMA Cardiol. 2020 06 01; 5(6):703-708.
    View in: PubMed
    Score: 0.056
  22. Novel biomarkers in cardiovascular disease: research tools or ready for personalized medicine? Cardiol Rev. 2012 May-Jun; 20(3):111-7.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.